Cleo Anastassopoulou (C Anastassopoulou)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 34

Top Venues

Journal of personalized medicine

Vaccines

Antibiotics (Basel, Switzerland)

PloS one

National and Kapodistrian University of Athens - Faculty of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National and Kapodistrian University of Athens - Faculty of Medicine

Greece

Associate Professor

University of Patras

Greece

Assistant Professor :: Biology

Massachusetts General Hospital

United States

Research Fellow :: Medicine, Division of Infectious Diseases

Harvard Medical School

United States

Research Fellow :: Medicine, Division of Infectious Diseases

Joan and Sanford I Weill Medical College of Cornell University

United States

Post-doctoral Research Associate :: Microbiology and Immunology

Publications

Stefanos Ferous, Cleo Anastassopoulou, Vassiliki C Pitiriga, Georgia Vrioni, Athanassios Tsakris
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 13 (3) (2024)
Cleo Anastassopoulou, Stefanos Ferous, Snežana Medić, Nikolaos Siafakas, Foteini Boufidou, Georgia Gioula, Athanassios Tsakris
Vaccines for the Elderly and Vaccination Programs in Europe and the United States. Vaccines 12 (6) (2024)
Stefanos Ferous, Nikolaos Siafakas, Foteini Boufidou, George P Patrinos, Athanassios Tsakris, Cleo Anastassopoulou
Investigating ABO Blood Groups and Secretor Status in Relation to SARS-CoV-2 Infection and COVID-19 Severity. Journal of personalized medicine 14 (4) (2024)
Stefanos Ferous, Cleo Anastassopoulou, Vassiliki C Pitiriga, Georgia Vrioni, Athanassios Tsakris
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 13 (3) (2024)
Stefanos Ferous, Cleo Anastassopoulou, Vassiliki C Pitiriga, Georgia Vrioni, Athanassios Tsakris
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 13 (3) (2024)
Panagiotis Siasios, Evangelia Giosi, Konstantinos Ouranos, Maria Christoforidi, Ifigenia Dimopoulou, Enada Leshi, Maria Exindari, Cleo Anastassopoulou, Georgia Gioula
Oropharyngeal Microbiome Analysis in Patients with Varying SARS-CoV-2 Infection Severity: A Prospective Cohort Study. Journal of personalized medicine 14 (4) (2024)
Panagiotis Siasios, Evangelia Giosi, Konstantinos Ouranos, Maria Christoforidi, Ifigenia Dimopoulou, Enada Leshi, Maria Exindari, Cleo Anastassopoulou, Georgia Gioula
Oropharyngeal Microbiome Analysis in Patients with Varying SARS-CoV-2 Infection Severity: A Prospective Cohort Study. Journal of personalized medicine 14 (4) (2024)
Cleo Anastassopoulou, Stefanos Ferous, Snežana Medić, Nikolaos Siafakas, Foteini Boufidou, Georgia Gioula, Athanassios Tsakris
Vaccines for the Elderly and Vaccination Programs in Europe and the United States. Vaccines 12 (6) (2024)
Stefanos Ferous, Nikolaos Siafakas, Foteini Boufidou, George P Patrinos, Athanassios Tsakris, Cleo Anastassopoulou
Investigating ABO Blood Groups and Secretor Status in Relation to SARS-CoV-2 Infection and COVID-19 Severity. Journal of personalized medicine 14 (4) (2024)
Cleo Anastassopoulou, Stefanos Ferous, Snežana Medić, Nikolaos Siafakas, Foteini Boufidou, Georgia Gioula, Athanassios Tsakris
Vaccines for the Elderly and Vaccination Programs in Europe and the United States. Vaccines 12 (6) (2024)
Stefanos Ferous, Cleo Anastassopoulou, Vassiliki C Pitiriga, Georgia Vrioni, Athanassios Tsakris
Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and Pseudomonas aeruginosa . Antibiotics (Basel, Switzerland) 13 (3) (2024)
Nikolaos Siafakas, Cleo Anastassopoulou, Maria Lafazani, Genovefa Chronopoulou, Emmanouil Rizos, Spyridon Pournaras, Athanassios Tsakris
Predominance of Recombinant Norovirus Strains in Greece, 2016-2018. Microorganisms 11 (12) (2023)
Nikolaos Siafakas, Cleo Anastassopoulou, Maria Lafazani, Genovefa Chronopoulou, Emmanouil Rizos, Spyridon Pournaras, Athanassios Tsakris
Predominance of Recombinant Norovirus Strains in Greece, 2016-2018. Microorganisms 11 (12) (2023)
Snežana Medić, Cleo Anastassopoulou, Tatjana Pustahija, Vladimir Petrović, Nataša Dragnić, Foteini Boufidou, Athanassios Tsakris, Vladan Šaponjić
Epidemiological Transition and Strategies for the Control of Hepatitis A in Serbia. Viruses 15 (3) (2023)
Foteini Boufidou, Sophia Hatziantoniou, Kalliopi Theodoridou, Helena C Maltezou, Konstantinos Z Vasileiou, Cleo Anastassopoulou, Snežana Medić, Athanassios Tsakris
Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data. Vaccines 11 (3) (2023)
Yiannis Manoussopoulos, Cleo Anastassopoulou, John P A Ioannidis, Athanassios Tsakris
Paired associated SARS-CoV-2 spike variable positions: a network analysis approach to emerging variants. mSystems (2023)
Snežana Medić, Cleo Anastassopoulou, Tatjana Pustahija, Vladimir Petrović, Nataša Dragnić, Foteini Boufidou, Athanassios Tsakris, Vladan Šaponjić
Epidemiological Transition and Strategies for the Control of Hepatitis A in Serbia. Viruses 15 (3) (2023)
Snežana Medić, Cleo Anastassopoulou, Tatjana Pustahija, Vladimir Petrović, Nataša Dragnić, Foteini Boufidou, Athanassios Tsakris, Vladan Šaponjić
Epidemiological Transition and Strategies for the Control of Hepatitis A in Serbia. Viruses 15 (3) (2023)
Foteini Boufidou, Sophia Hatziantoniou, Kalliopi Theodoridou, Helena C Maltezou, Konstantinos Z Vasileiou, Cleo Anastassopoulou, Snežana Medić, Athanassios Tsakris
Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data. Vaccines 11 (3) (2023)
Foteini Boufidou, Snežana Medić, Vicky Lampropoulou, Nikolaos Siafakas, Athanassios Tsakris, Cleo Anastassopoulou
SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic. International journal of molecular sciences 24 (16) (2023)
Cleo Anastassopoulou, Dimitra Antoni, Yiannis Manoussopoulos, Panagiotis Stefanou, Sofia Argyropoulou, Georgia Vrioni, Athanassios Tsakris
Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods. PloS one 17 (4) (2022)
Sophia Hatziantoniou, Cleo Anastassopoulou, George Lazaros, Konstantinos Vasileiou, Costas Tsioufis, Athanassios Tsakris
Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States. Expert review of vaccines 21 (11) (2022)
Evita Athanasiou, Antonios N Gargalionis, Cleo Anastassopoulou, Athanassios Tsakris, Foteini Boufidou
New Insights into the Molecular Interplay between Human Herpesviruses and Alzheimer's Disease-A Narrative Review. Brain sciences 12 (8) (2022)
Cleo Anastassopoulou, Sophia Hatziantoniou, Foteini Boufidou, George P Patrinos, Athanassios Tsakris
The Role of Oral Antivirals for COVID-19 Treatment in Shaping the Pandemic Landscape. Journal of personalized medicine 12 (3) (2022)
Sophia Hatziantoniou, Cleo Anastassopoulou, Vicky Lampropoulou, Helena C Maltezou, Evangelos Andreakos, Gregory A Poland, Athanassios Tsakris
Comparative assessment of allergic reactions to COVID-19 vaccines in Europe and the United States. Allergy 77 (5) (2022)
Elisabeth Kapaki, Foteini Boufidou, Mara Bourbouli, Efstratios-Stylianos Pyrgelis, Vasilios C Constantinides, Cleo Anastassopoulou, Georgios P Paraskevas
Cerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal Dementia. Journal of personalized medicine 12 (10) (2022)
Constantinos I Siettos, Cleo Anastassopoulou, Constantinos Tsiamis, Georgia Vrioni, Athanassios Tsakris
A bulletin from Greece: a health system under the pressure of the second COVID-19 wave. Pathogens and global health 115 (3) (2021)
Cleo Anastassopoulou, Constantinos I Siettos, Lucia Russo, Georgia Vrioni, Athanassios Tsakris
Lessons from the devastating impact of the first COVID-19 wave in Italy. Pathogens and global health 115 (4) (2021)
Cleo Anastassopoulou, Yiannis Manoussopoulos, Vicky Lampropoulou, Athanassios Tsakris
Glimpses into evolutionary trajectories of SARS-CoV-2: emerging variants and potential immune evasion routes. Future microbiology 16 (2021)
Cleo Anastassopoulou, Zoi Gkizarioti, George P Patrinos, Athanassios Tsakris
Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity. Human genomics 14 (1) (2020)
Lucia Russo, Cleo Anastassopoulou, Athanasios Tsakris, Gennaro Nicola Bifulco, Emilio Fortunato Campana, Gerardo Toraldo, Constantinos I Siettos
Tracing day-zero and forecasting the COVID-19 outbreak in Lombardy, Italy: A compartmental modelling and numerical optimization approach. PloS one 15 (10) (2020)
Cleo Anastassopoulou, Nicholas Spanakis, Athanassios Tsakris
SARS-CoV-2 transmission, the ambiguous role of children and considerations for the reopening of schools in the fall. Future microbiology 15 (2020)
Snežana Medić, Cleo Anastassopoulou, Vesna Milošević, Nataša Dragnić, Smiljana Rajčević, Mioljub Ristić, Vladimir Petrović
Declining seroprevalence of hepatitis A in Vojvodina, Serbia. PloS one 14 (6) (2019)
Snežana Medić, V Petrović, V Milosević, Z Lozanov-Crvenković, S Brkić, N Andrews, F de Ory, Cleo Anastassopoulou
Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia. Epidemiology and infection 146 (12) (2018)

Cleo Anastassopoulou.css-eqlu8i{font-size:small;padding-left:4px;} (C Anastassopoulou)

Publication Activity (10 Years)

Top Topics

Top Venues

Cleo Anastassopoulou (C Anastassopoulou)